| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 222.93 mm | 222.93 mm | 222.93 mm | 222.93 mm | 222.93 mm | 222.93 mm |
| Cash burn (monthly) | 155.33 k | 880.58 k | 8.12 mm | 7.41 mm | 1.69 mm | (no burn) |
| Cash used (since last report) | 354.94 k | 2.01 mm | 18.56 mm | 16.94 mm | 3.86 mm | n/a |
| Cash remaining | 222.57 mm | 220.92 mm | 204.37 mm | 205.99 mm | 219.07 mm | n/a |
| Runway (months of cash) | 1432.9 | 250.9 | 25.2 | 27.8 | 129.7 | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 206 |
| Opened positions | 41 |
| Closed positions | 18 |
| Increased positions | 74 |
| Reduced positions | 59 |
| 13F shares | Current |
|---|---|
| Total value | 2.05 tn |
| Total shares | 63.42 mm |
| Total puts | 99.70 k |
| Total calls | 2.60 k |
| Total put/call ratio | 38.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Frazier Life Sciences Management | 6.57 mm | $271.69 bn |
| JHG Janus Henderson | 4.58 mm | $189.48 bn |
| Frazier Life Sciences IX | 3.57 mm | $94.27 mm |
| BlackRock | 3.43 mm | $142.02 bn |
| Biotechnology Value Fund L P | 3.08 mm | $120.51 mm |
| BVF | 2.80 mm | $115.64 bn |
| Eventide Asset Managment | 2.61 mm | $107.80 bn |
| Vanguard | 2.42 mm | $100.26 bn |
| New Enterprise Associates 16 | 2.19 mm | $65.78 mm |
| RiverVest Venture Fund IV | 1.62 mm | $32.28 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Mar 25 | Patrick J Heron | Common Stock | Buy | Acquire P | Yes | No | 44.545 | 267 | 11.89 k | 163,910 |
| 4 Mar 25 | Radovich Peter | Common Stock | Sell | Dispose S | No | No | 45.74 | 1,169 | 53.47 k | 12,111 |
| 4 Mar 25 | Radovich Peter | Common Stock | Sell | Dispose S | No | No | 45.5711 | 13,681 | 623.46 k | 13,280 |
| 4 Mar 25 | Patrick J Heron | Common Stock | Buy | Acquire P | Yes | No | 45.9597 | 56 | 2.57 k | 163,643 |
| 4 Mar 25 | Patrick J Heron | Common Stock | Buy | Acquire P | Yes | No | 45.5486 | 1,279 | 58.26 k | 163,587 |
| 3 Mar 25 | Christopher Peetz | Common Stock | Sell | Dispose S | No | Yes | 47.19 | 20,608 | 972.49 k | 115,920 |
| 3 Mar 25 | Christopher Peetz | Common Stock | Sell | Dispose S | No | Yes | 46.61 | 19,392 | 903.86 k | 136,528 |
| 3 Mar 25 | Christopher Peetz | Common Stock | Option exercise | Acquire M | No | No | 2.936 | 40,000 | 117.44 k | 155,920 |
| 3 Mar 25 | Christopher Peetz | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.936 | 40,000 | 117.44 k | 238,487 |
| 3 Feb 25 | Radovich Peter | Common Stock | Sell | Dispose S | No | No | 48.2226 | 2,627 | 126.68 k | 26,961 |
